fda warning letters bpc-157 2024 2025 BPC-157: Miracle Healing Peptide or Hidden Danger? An FDA Committee Just Voted

Sublingual troches / lozenges: 50200 mcg per troche, 12 times daily , dissolved between cheek and gum for 1520 minutes

The legitimate worry with sustained NNMT inhibition isnt tolerance in the receptor sense

Peptidbasierte Medikamente werden in der Regel als Injektionen, Augentropfen oder Infusionen verabreicht

If someone has levels above 350nanograms/L, they are unlikely to have B12 deficiency

They found that increased lung tissue stiffness only occurred where there were higher amounts of the mature cross-linked collagen and that, in these samples, the structure of each collagen building block or fibril was altered